Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
101.77
-1.87 (-1.80%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $6.98 billion as of April 25, 2025. Its market cap has increased by 68.65% in one year.
Market Cap
6.98B
Enterprise Value
6.69B
1-Year Change
68.65%
Ranking
Category
Stock Price
$101.77
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $6.98B, an increase of 3,803.06%. That is a compound annual growth rate of 45.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 7.10B | 14.10% |
| Dec 31, 2024 | 6.22B | 46.48% |
| Dec 29, 2023 | 4.25B | 21.06% |
| Dec 30, 2022 | 3.51B | 79.37% |
| Dec 31, 2021 | 1.96B | 116.78% |
| Dec 31, 2020 | 902.10M | 12.06% |
| Dec 31, 2019 | 805.00M | 33.72% |
| Dec 31, 2018 | 602.00M | -21.51% |
| Dec 29, 2017 | 767.00M | 149.67% |
| Dec 30, 2016 | 307.20M | 188.72% |
| Dec 31, 2015 | 106.40M | -40.53% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.41B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |